LIFECORE BIOMEDICAL, INC. Cash and Cash Equivalents, Period Increase (Decrease)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.52 million for the 12-month period ending 2018-05-27, per its 10-K filed 2018-08-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-08-09
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-05-27 was -$4.76M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-02-25 was $3.28M, a 67.73% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-11-26 was -$3.82M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-08-27 was $2.78M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$2.52M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$4.49M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$4.23M.
- LIFECORE BIOMEDICAL, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$116.00K, a 122.10% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-05-27 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$1.48M derived: sum of 2 quarters · filed 2018-08-09 | -$5.30M derived: sum of 3 quarters · filed 2018-08-09 | -$2.52M 10-K · filed 2018-08-09 |
| 2018-02-25 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$541.00K derived: sum of 2 quarters · filed 2018-04-05 | $2.24M 10-Q · filed 2018-04-05 | -$5.08M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-11-26 | -$3.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$1.04M 10-Q · filed 2018-01-05 | -$8.37M derived: sum of 3 quarters · filed 2018-08-09 | $1.80M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-08-27 | $2.78M 10-Q · filed 2017-09-28 | -$4.54M derived: sum of 2 quarters · filed 2018-08-09 | $5.63M derived: sum of 3 quarters · filed 2018-08-09 | -$435.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-05-28 | -$7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $2.84M derived: sum of 2 quarters · filed 2018-08-09 | -$3.22M derived: sum of 3 quarters · filed 2018-08-09 | -$4.49M 10-K · filed 2018-08-09 |
| 2017-02-26 | $10.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $4.11M derived: sum of 2 quarters · filed 2018-04-05 | $2.84M 10-Q · filed 2018-04-05 | $4.52M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-11-27 | -$6.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | -$7.33M 10-Q · filed 2018-01-05 | -$5.65M derived: sum of 3 quarters · filed 2018-08-09 | -$3.41M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-08-28 | -$1.27M 10-Q · filed 2017-09-28 | $412.00K derived: sum of 2 quarters · filed 2018-08-09 | $2.65M derived: sum of 3 quarters · filed 2018-08-09 | $1.52M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-05-29 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $3.92M derived: sum of 2 quarters · filed 2018-08-09 | $2.79M derived: sum of 3 quarters · filed 2018-08-09 | -$4.23M 10-K · filed 2018-08-09 |
| 2016-02-28 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | $1.11M derived: sum of 2 quarters · filed 2017-04-07 | -$5.91M 10-Q · filed 2017-04-07 | -$7.48M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-11-29 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | -$8.15M 10-Q · filed 2017-01-05 | -$9.72M derived: sum of 3 quarters · filed 2018-03-15 | $1.00M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-08-30 | -$7.02M 10-Q · filed 2016-09-29 | -$8.59M derived: sum of 2 quarters · filed 2018-03-15 | $2.13M derived: sum of 3 quarters · filed 2018-03-15 | -$1.43M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-05-31 | -$1.57M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $9.16M derived: sum of 2 quarters · filed 2018-03-15 | $5.60M derived: sum of 3 quarters · filed 2018-03-15 | -$116.00K 10-K/A · filed 2018-03-15 |
| 2015-03-01 | $10.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $7.17M derived: sum of 2 quarters · filed 2016-03-30 | $1.45M 10-Q · filed 2016-03-30 | $2.71M derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-11-30 | -$3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | -$9.27M 10-Q · filed 2016-01-07 | -$8.02M derived: sum of 3 quarters · filed 2016-08-01 | -$796.00K derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-08-31 | -$5.71M 10-Q · filed 2015-10-01 | -$4.46M derived: sum of 2 quarters · filed 2016-08-01 | $2.76M derived: sum of 3 quarters · filed 2016-08-01 | -$368.00K derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-05-25 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $8.48M derived: sum of 2 quarters · filed 2016-08-01 | $5.35M derived: sum of 3 quarters · filed 2016-08-01 | $525.00K 10-K · filed 2016-08-01 |
| 2014-02-23 | $7.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $4.09M derived: sum of 2 quarters · filed 2015-04-02 | -$731.00K 10-Q · filed 2015-04-02 | $3.04M derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-11-24 | -$3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$7.95M 10-Q · filed 2015-01-09 | -$4.18M derived: sum of 3 quarters · filed 2015-07-31 | $910.00K derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-08-25 | -$4.82M 10-Q · filed 2013-09-26 | -$1.05M derived: sum of 2 quarters · filed 2015-07-31 | $4.04M derived: sum of 3 quarters · filed 2015-07-31 | -$1.15M derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-05-26 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $8.86M derived: sum of 2 quarters · filed 2015-07-31 | $3.67M derived: sum of 3 quarters · filed 2015-07-31 | -$8.46M 10-K · filed 2015-07-31 |
| 2013-02-24 | $5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$106.00K derived: sum of 2 quarters · filed 2014-03-28 | -$12.23M 10-Q · filed 2014-03-28 | -$2.59M derived: sum of 4 quarters · filed 2014-03-28 |
| 2012-11-25 | -$5.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$17.32M 10-Q · filed 2014-01-03 | -$7.68M derived: sum of 3 quarters · filed 2014-01-03 | $621.00K derived: sum of 4 quarters · filed 2014-01-03 |
| 2012-08-26 | -$12.13M 10-Q · filed 2013-09-26 | -$2.48M derived: sum of 2 quarters · filed 2013-09-26 | $5.81M derived: sum of 3 quarters · filed 2013-09-26 | $2.81M derived: sum of 4 quarters · filed 2013-09-26 |
| 2012-05-27 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $17.94M derived: sum of 2 quarters · filed 2013-08-07 | $14.94M derived: sum of 3 quarters · filed 2013-08-07 | $14.04M 10-K · filed 2013-08-07 |
| 2012-02-26 | $8.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $5.29M derived: sum of 2 quarters · filed 2013-04-04 | $4.40M 10-Q · filed 2013-04-04 | $5.86M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-11-27 | -$3.01M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$3.90M 10-Q · filed 2013-01-04 | -$2.44M derived: sum of 3 quarters · filed 2013-08-07 | |
| 2011-08-28 | -$893.00K 10-Q/A · filed 2013-01-02 | $563.00K derived: sum of 2 quarters · filed 2013-08-07 | ||
| 2011-05-29 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$19.68M 10-K · filed 2013-08-07 | ||
| 2011-02-27 | -$21.14M 10-Q · filed 2012-03-28 | |||
| 2010-11-28 | -$22.37M 10-Q · filed 2012-01-05 | |||
| 2010-08-29 | -$17.92M 10-Q · filed 2011-10-05 | |||
| 2010-05-30 | -$15.64M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |